New Delhi|HL
The Sevelamer Carbonate tablets of Drug firm Aurobindo Pharma has received final approval from the USFDA to manufacture it in the American market.
The tablets are indicated for control of serum phosphorus in patients with chronic kidney disease on dialysis.
“The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture Sevelamer Carbonate tablets 800 mg,” Aurobindo Pharma said in a BSE filing today.
